Back to Results
First PageMeta Content
Drug discovery / Pharmaceutical industry / Clinical research / Consortium / Pharmacology / Pharmaceutical sciences / Critical Path Institute


Welcome and PRO Consortium Update Stephen Joel Coons, PhD Executive Director, PRO Consortium FIFTH ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP April[removed], 2014  Silver Spring, MD
Add to Reading List

Document Date: 2014-05-20 15:29:24


Open Document

File Size: 390,68 KB

Share Result on Facebook

Company

Bayer Pharma AG / GlaxoSmithKline LLC / /

Facility

Forest Research Institute / Critical Path Institute / Acknowledgments Critical Path Institute / /

IndustryTerm

pharmaceutical industry / pharmaceutical firms / /

MedicalCondition

Lung Cancer / NSCLC / PRO instruments PRO Consortium Member Firms PRO Consortium Working Groups Asthma / nighttime asthma / Rheumatoid Arthritis / Irritable Bowel Syndrome / Depression / /

Organization

Critical Path Institute / Acknowledgments Critical Path Institute / U. S. Food and Drug Administration / Forest Research Institute / /

Person

Michelle Mocarski / Stephen Joel Coons / Linda Nelsen / /

Position

PhD Executive Director / Director / PRO Consortium / /

SocialTag